腹膜后肿瘤外科治疗进展和争议  

Progress and controversy in surgical treatment of retroperitoneal sarcomas

作　　者：闾晨涛 陆维祺 Lyu Chentao;Lu Weiqi(Department of General Surgery,Shanghai Public Health Clinical Center/South Zhongshan Hospital of Fudan University,Shanghai 200083,China;Department of General Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属(上海市)公共卫生临床中心/复旦大学附属中山医院南院普外科,200083 [2]复旦大学附属中山医院普外科,上海200032

出　　处：《中华疝和腹壁外科杂志（电子版）》2019年第6期503-505,共3页Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition)

摘　　要：腹膜后肿瘤,主要是软组织肉瘤是一类来源于结缔组织的少见恶性肿瘤,异质性高,病理类型复杂,推荐应在具备多学科协作团队的区域性肉瘤中心进行综合治疗。对局部肿瘤施以切缘阴性的完整手术切除是对原发性腹膜后肉瘤(RPS)患者标准的、潜在根治性治疗,可以说外科治疗是RPS综合治疗的基础。近年来,腹膜后肿瘤的外科治疗取得了一些进展,同时存在一些争议。外科治疗在进展和争议中逐步成熟。Retroperitoneal tumors,mainly soft tissue sarcomas,are a rare type of malignant tumors derived from connective tissue,with high heterogeneity and complex pathological types.Comprehensive treatment is recommended at regional sarcoma centers with multidisciplinary team teams.A complete surgical resection with negative margin for local tumors is a standard,potentially radical treatment for patients with retroperitoneal sarcoma(RPS).It can be said that surgical treatment is the basis for comprehensive treatment of RPS.In recent years,some progress has been made in the surgical treatment of retroperitoneal tumors,while there are some controversies.Surgical treatment has matured in progress and controversy.

关 键 词：软组织肉瘤 腹膜后肿瘤 外科治疗 

分 类 号：R73[医药卫生—肿瘤]